Proinsulin‐specific T‐cell responses correlate with estimated c‐peptide and predict partial remission duration in type 1 diabetes-Reference-Cited by-同舟云学术

Proinsulin‐specific T‐cell responses correlate with estimated c‐peptide and predict partial remission duration in type 1 diabetes

Published:2021-01 Issue:7 Volume:10 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Musthaffa Yassmin¹²^ORCID,Hamilton‐Williams Emma E²^ORCID,Nel Hendrik J²^ORCID,Bergot Anne‐Sophie²^ORCID,Mehdi Ahmed M²^ORCID,Harris Mark¹²,Thomas Ranjeny²^ORCID

Affiliation:

1. Department of Endocrinology and Diabetes Queensland Children’s Hospital South Brisbane QLD Australia

2. The University of Queensland Diamantina Institute The University of Queensland Brisbane QLD Australia

Funder

Juvenile Diabetes Research Foundation Australia

Royal Australasian College of Physicians

University of Queensland

Leona M. and Harry B. Helmsley Charitable Trust

National Health and Medical Research Council

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1315

Reference54 articles.

1. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes

2. Current Concepts on the Pathogenesis of Type 1 Diabetes—Considerations for Attempts to Prevent and Reverse the Disease

3. An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes

4. Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells

5. Effect of Intensive Therapy on Residual β-Cell Function in Patients with Type 1 Diabetes in the Diabetes Control and Complications Trial

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic cells and antigen-specific immunotherapy in autoimmune rheumatic diseases;Best Practice & Research Clinical Rheumatology;2024-05

2. Th2 cell clonal expansion at diagnosis in human type 1 diabetes;Clinical Immunology;2023-12

3. Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus;Trends in Endocrinology & Metabolism;2023-11

4. What Is a Honeymoon in Type 1, Can It Go into Remission?;Endocrinology and Metabolism Clinics of North America;2023-03

5. The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes;Frontiers in Immunology;2023-01-17